Cardiol Rev 12(4):201221 Quinney SK, Mohamed AN, Hebert MF, Haas DM, Clark S, Umans JG et al (2012) A semi-mechanistic metabolism model of CYP3A substrates in pregnancy: predicting changes in midazolam and nifedipine pharmacokinetics
2021 is a year of new optimism, a different kind of normal, a time to reset and take a breath
Cotadutide, but not liraglutide improved hepatic parameters and metabolic dysfunction-associated steatohepatitis (MASH) with similar weight loss with 200 g cotadutide compared to 1.8 mg liraglutide and greater with 300 g cotadutide versus 1.8 mg liraglutide [47]
Officioso A, Alzoubi K, Manna C, Lang F
A Phase 2 trial for ulcerative colitis was conducted by Diagen (Croatia)